Quote | Bright Minds Biosciences Inc. (NASDAQ:DRUG)
Last: | $0.99 |
---|---|
Change Percent: | 2.48% |
Open: | $1.02 |
Close: | $0.99 |
High: | $1.06 |
Low: | $0.98 |
Volume: | 24,368 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
News | Bright Minds Biosciences Inc. (NASDAQ:DRUG)
2024-04-29 13:37:07 ET More on psychedelic drug developers Psychedelic drugs market to break $7B in 2029 led by these 3 meds Cybin spikes after FDA breakthrough tag for psychedelic therapy Psychedelic stocks gain after FDA priority review for MDMA therapy ...
2024-03-07 11:29:12 ET More on Clearmind Medicine, Bright Minds, etc. Mind Medicine (MindMed) Inc. (MNMD) Q4 2023 Earnings Call Transcript Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...
Message Board Posts | Bright Minds Biosciences Inc. (NASDAQ:DRUG)
Subject | By | Source | When |
---|---|---|---|
Interesting. But yea, I changed over pretty | Vipyr | investorshub | 04/26/2023 7:42:35 AM |
I have bought them thru Etrade. I get | skichic | investorshub | 04/25/2023 8:53:55 PM |
True lol Had to answer your | Vipyr | investorshub | 04/25/2023 6:40:06 PM |
Very good post!!! Thank you. | DJS1 | investorshub | 04/21/2023 1:54:27 AM |
And this forum goes back to silent mode. Just | Smilin_B | investorshub | 04/21/2023 12:04:17 AM |
News, Short Squeeze, Breakout and More Instantly...
Bright Minds Biosciences Inc. Company Name:
DRUG Stock Symbol:
NASDAQ Market:
Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...
Bright Minds Biosciences Inc. (DRUG) is expected to report for quarter end 2023-12-31
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned ...